These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30248922)

  • 1. An Evaluation of the Potential of NMR Spectroscopy and Computational Modelling Methods to Inform Biopharmaceutical Formulations.
    Pandya A; Howard MJ; Zloh M; Dalby PA
    Pharmaceutics; 2018 Sep; 10(4):. PubMed ID: 30248922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking mAb-excipient interactions in biologics formulations by NMR spectroscopy and computational approaches.
    Zhang C; Gossert ST; Williams J; Little M; Barros M; Dear B; Falk B; Kanthe AD; Garmise R; Mueller L; Ilott A; Abraham A
    MAbs; 2023; 15(1):2212416. PubMed ID: 37218059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Protein-Excipient Interaction Hotspots Using Computational Approaches.
    Barata TS; Zhang C; Dalby PA; Brocchini S; Zloh M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27258262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using
    Bramham JE; Podmore A; Davies SA; Golovanov AP
    ACS Pharmacol Transl Sci; 2021 Feb; 4(1):288-295. PubMed ID: 33659867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDX and In Silico Docking Reveal that Excipients Stabilize G-CSF via a Combination of Preferential Exclusion and Specific Hotspot Interactions.
    Wood VE; Groves K; Cryar A; Quaglia M; Matejtschuk P; Dalby PA
    Mol Pharm; 2020 Dec; 17(12):4637-4651. PubMed ID: 33112626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling Insulin Oligomeric States by
    Falk BT; Liang Y; McCoy MA
    J Pharm Sci; 2020 Jan; 109(1):922-926. PubMed ID: 31449814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a fast screening method for selecting excipients in formulations using MD simulations, NMR and microscale thermophoresis.
    Indrakumar S; Zalar M; Tschammer N; Pohl C; Nørgaard A; Streicher W; Harris P; Golovanov AP; Peters GHJ
    Eur J Pharm Biopharm; 2021 Jan; 158():11-20. PubMed ID: 33137420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
    Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
    MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-Excipient Interactions Evaluated via Nuclear Magnetic Resonance Studies in Polysorbate-Based Multidose Protein Formulations: Influence on Antimicrobial Efficacy and Potential Study Approach.
    Torosantucci R; Furtmann B; Elshorst B; Pfeiffer-Marek S; Hartleb T; Andres N; Bussemer T
    J Pharm Sci; 2018 Oct; 107(10):2531-2537. PubMed ID: 29883667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of biopharmaceutical formulations by Time Domain Nuclear Magnetic Resonance (TD-NMR) spectroscopy: A potential method for detection of counterfeit biologic pharmaceuticals.
    Akhunzada Z; Wu Y; Haby T; Jayawickrama D; McGeorge G; La Colla M; Bernstein J; Semones M; Abraham A
    J Pharm Sci; 2021 Jul; 110(7):2765-2770. PubMed ID: 33745914
    [No Abstract]   [Full Text] [Related]  

  • 14. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
    Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
    J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering Novel Small Molecule Compound for Prevention of Monoclonal Antibody Self-Association.
    Lui LH; van der Walle CF; Brocchini S; Velayudhan A
    Antibodies (Basel); 2022 Jun; 11(2):. PubMed ID: 35735359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of water on the stability of lyophilized formulations with inositol and mannitol as excipients.
    Terakita A; Matsunaga H; Handa T
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):459-63. PubMed ID: 19420775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-protein interactions and water activity coefficients can be used to aid a first excipient choice in protein formulations.
    Schleinitz M; Sadowski G; Brandenbusch C
    Int J Pharm; 2019 Oct; 569():118608. PubMed ID: 31415881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid optimization of protein freeze-drying formulations using ultra scale-down and factorial design of experiment in microplates.
    Grant Y; Matejtschuk P; Dalby PA
    Biotechnol Bioeng; 2009 Dec; 104(5):957-64. PubMed ID: 19530082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.
    Kamerzell TJ; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    Adv Drug Deliv Rev; 2011 Oct; 63(13):1118-59. PubMed ID: 21855584
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.